open access

Vol 9, No 6 (2020)
Letter to the Editor
Published online: 2020-12-02
Get Citation

Is there a need for a treatment for COVID-19-induced diabetes?

Antonio Vitiello, Francesco Ferrara
DOI: 10.5603/DK.2020.0066
·
Clinical Diabetology 2020;9(6):378.

open access

Vol 9, No 6 (2020)
COVID-19 AND DIABETES
Published online: 2020-12-02

Abstract

n/a

Abstract

n/a

Get Citation

Keywords

diabetes, DPP4/CD26, SARS-CoV-2, glyptins, glycemic

About this article
Title

Is there a need for a treatment for COVID-19-induced diabetes?

Journal

Clinical Diabetology

Issue

Vol 9, No 6 (2020)

Article type

Letter to the Editor

Pages

378

Published online

2020-12-02

DOI

10.5603/DK.2020.0066

Bibliographic record

Clinical Diabetology 2020;9(6):378.

Keywords

diabetes
DPP4/CD26
SARS-CoV-2
glyptins
glycemic

Authors

Antonio Vitiello
Francesco Ferrara

References (8)
  1. Li J, Wang X, Chen J, et al. COVID-19 infection may cause ketosis and ketoacidosis. Diabetes Obes Metab. 2020 [Epub ahead of print].
  2. Hamming I, Timens W, Bulthuis MLC, et al. Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis. J Pathol. 2004; 203(2): 631–637.
  3. Yang JK, Lin SS, Ji XJ, et al. Binding of SARS coronavirus to its receptor damages islets and causes acute diabetes. Acta Diabetol. 2010; 47(3): 193–199.
  4. Vitiello A, Ferrara F. Correlation between renin-angiotensin system and Severe Acute Respiratory Syndrome Coronavirus 2 infection: What do we know? Eur J Pharmacol. 2020; 883: 173373.
  5. Vankadari N, Wilce JA. Emerging WuHan (COVID-19) coronavirus: glycan shield and structure prediction of spike glycoprotein and its interaction with human CD26. Emerg Microbes Infect. 2020; 9(1): 601–604.
  6. Qi F, Qian S, Zhang S, et al. Single cell RNA sequencing of 13 human tissues identify cell types and receptors of human coronaviruses. Biochem Biophys Res Commun. 2020; 526(1): 135–140.
  7. Waumans Y, Baerts L, Kehoe K, et al. The dipeptidyl peptidase family, prolyl oligopeptidase, and prolyl carboxypeptidase in the immune system and inflammatory disease, including atherosclerosis. Front Immunol. 2015; 6: 387.
  8. Ferrara F, Vitiello A. The impact of COVID-19 in diabetic patient. Arch Med Health Sci. 2020; 8(1): 167–171.

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

 

Wydawcą serwisu jest  "Via Medica sp. z o.o." sp.k., ul. Świętokrzyska 73, 80–180 Gdańsk

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail:  viamedica@viamedica.pl